blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1879592

EP1879592 - USE OF INHIBITORS OF STEROID (TESTOSTERONE) ACTIVITY (I.A. ESTROGENS) OR ANTIANDROGENS) FOR TREATMENT OF SUBSTANCE CORRELATED DISORDERS LIKE DRUG ABUSE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.03.2012
Database last updated on 15.06.2024
Most recent event   Tooltip16.03.2012Application deemed to be withdrawnpublished on 18.04.2012  [2012/16]
Applicant(s)For all designated states
La Pera, Giuseppe
Viale delle Milizie 76
00192 Roma / IT
[2008/04]
Inventor(s)01 / see applicant
...
 [2008/04]
Representative(s)Gitto, Serena, et al
Barzanò & Zanardo Roma S.p.A.
Via Piemonte, 26
00187 Roma / IT
[N/P]
Former [2008/04]Gitto, Serena, et al
Barzanò & Zanardo Roma S.p.A. Via Piemonte, 26
I-00187 Roma / IT
Application number, filing date06728498.417.03.2006
[2008/04]
WO2006IT00168
Priority number, dateIT2005RM0012718.03.2005         Original published format: IT RM20050127
[2008/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006097970
Date:21.09.2006
Language:EN
[2006/38]
Type: A1 Application with search report 
No.:EP1879592
Date:23.01.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 21.09.2006 takes the place of the publication of the European patent application.
[2008/04]
Search report(s)International search report - published on:EP21.09.2006
ClassificationIPC:A61K31/56, A61K31/57, A61P5/00, A61P25/30, A61P43/00
[2008/04]
CPC:
A61K31/56 (EP,US); A61K31/57 (EP,US); A61P25/30 (EP);
A61P43/00 (EP); A61P5/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/04]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERWENDUNG VON HEMMERN DER STEROID (TESTOSTERON) AKTIVITÄT (U.A. ÖSTROGENE ODER ANDROGENE) ZUR BEHANDLUNG VON SUBSTANZBEDINGTEN ERKRANKUNGEN, WIE Z.B. DROGENMISSBRAUCH[2008/04]
English:USE OF INHIBITORS OF STEROID (TESTOSTERONE) ACTIVITY (I.A. ESTROGENS) OR ANTIANDROGENS) FOR TREATMENT OF SUBSTANCE CORRELATED DISORDERS LIKE DRUG ABUSE[2008/04]
French:UTILISATION D'INHIBITEURS (PAR EXAMPLE DES ESTROGENES OU DES ANDROGENES) DE L'ACTIVITE STEROIDE (TESTOSTERON) POUR LE TRAITEMENT DES MALADIES LIEES A LA PRISE DE PRINCIPES ACTIFS, COMME PAR EXAMPLE L'ABUS DE DROGUE[2008/04]
Entry into regional phase05.10.2007National basic fee paid 
05.10.2007Designation fee(s) paid 
05.10.2007Examination fee paid 
Examination procedure05.10.2007Examination requested  [2008/04]
09.10.2008Despatch of a communication from the examining division (Time limit: M06)
17.04.2009Reply to a communication from the examining division
01.10.2011Application deemed to be withdrawn, date of legal effect  [2012/16]
14.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/16]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.10.2008
Fees paidRenewal fee
27.02.2008Renewal fee patent year 03
23.02.2009Renewal fee patent year 04
12.03.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - LAKOZA G N ET AL, "SIGNIFICANCE OF THE ADRENOLYTIC PROPERTIES OF NEUROLEPTICS IN THEIR EFFECT ON ETHANOL ADDICTION", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1981), Database accession no. PREV198376037216, XP002391944 [X] 1-17 * abstract *
    [ ] - FARMAKOLOGIYA I TOKSIKOLOGIYA (MOSCOW), (1981), vol. 44, no. 2, ISSN 0014-8318, pages 151 - 154
 [X]  - G.N. LAKOZA, N.K. BARKOV, "The role of testosterone in the development of experimental alcoholism", UNITED NATIONS BULLETIN ON NARCOTICS, no. 2, (1980), pages 41 - 48, URL: http://www.unodc.org/unodc/bulletin/bulletin_1980-01-01_2_page007.html#s070, (20060726), XP002392127 [X] 1-17 * "Results and discussion" para 18-20 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.